US equities |
SPCX $166.96 ▲+5.03% NVDA $236.76 ▲+1.20% MU $1,063.79 ▼-1.03% TSLA $376.88 ▲+1.70% MSFT $524.58 ▲+1.36% SNDK $1,706.52 ▼-0.78% INTC $117.60 ▼-1.45% META $742.78 ▲+2.02%
FinancialContent

Cue Biopharma, Inc. - Common Stock (NQ:CUE)

23.35 -2.22 (-8.68%)
Delayed Quote Updated: 12:09 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cue Biopharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >